Omeprazole Cristers Pharma

Omeprazole, the active ingredient in Omeprazole Cristers Pharma, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat acid‑related gastrointestinal conditions in adults and children when appropriate. GNH USA supplies Omeprazole Cristers Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that reduces gastric acid secretion in acid‑related disorders.

- Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: accelerates healing of gastric and duodenal ulcers and helps prevent recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Adverse reactions may occur with Omeprazole use.

Common Side Effects: - Headache: mild to moderate pain often transient. - Abdominal pain: discomfort or cramping in the stomach region. - Diarrhea: loose stools that may be watery. - Nausea: feeling of unease or urge to vomit. - Flatulence: excess gas in the gastrointestinal tract. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Stevens‑Johnson syndrome: painful skin blistering and mucosal involvement. - Liver enzyme elevation: signs of hepatic stress detectable in labs. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat. - Increased risk of bone fracture: especially with long‑term use.

Before initiating therapy, consider patient‑specific factors and monitor for potential issues. - Assess renal and hepatic function: dose adjustment may be needed in impairment. - Use with caution in the elderly: increased susceptibility to adverse effects. - Avoid prolonged use without clear indication: long‑term therapy may raise fracture risk. - Monitor magnesium levels during extended treatment: supplement if deficiency arises. - Review concomitant medications that affect absorption or metabolism: adjust as necessary. - Store at room temperature: keep in the original pack, protect from moisture.

Omeprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: markedly decreased antiviral exposure, compromising HIV therapy. - Ketoconazole: impaired antifungal absorption, reducing efficacy.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels, risk of toxicity. - Methotrexate: elevated concentrations, especially at high doses. - Calcium carbonate: reduced absorption of both agents, may require timing adjustments.